Healthcare Industry Embraces Quantum-Secure Data Solutions and AI Innovations

With Quantum Threats Looming, Major Healthcare Players Turn to Quantum-Secure Data Solutions - IonQ (NYSE:IONQ)

USA News Group News Commentary Issued on behalf of Scope Technologies Corp. VANCOUVER, BC, Nov. 14, 2024 /PRNewswire/ -- USA News Group News Commentary - With the advent of new quantum-computing tools on the horizon for both enterprises and hackers alike, experts are warning for a global shift towards quantum-secure cryptography in the healthcare sector. Experts writing for IBM are calling on CIOs to prepare their organizations today for quantum-safe cryptography, especially in healthcare and life sciences. Now 85% of industry leaders are calling for major investments in quantum computing. Behind the scenes are several developments and partnerships being orchestrated by tech companies offering quantum-computing related solutions, including from Scope Technologies Corp. SCPE SCPCF, SEALSQ Corp. LAES, D-Wave Quantum Inc. QBTS, Rigetti Computing, Inc. RGTI RGTIW)), and IonQ, Inc. IONQ. The article continued: According to analysts at MarketsandMarkets, the Quantum Computing in Healthcare Market is projected to skyrocket at a 42.5% CAGR from US$85 million in 2023 to US$503 million by 2028. Earlier this year, Heliyon published an article in ScienceDirect about how post-quantum healthcare provides a roadmap for cybersecurity resilience in medical data. Scope Technologies Forms Strategic Alliance with Global Care Innovations and BitLab to Drive Advanced AI and Quantum Security Solutions for Healthcare Across North America Scope Technologies Corp. SCPE SCPCF, a pioneering technology company specializing in quantum security and machine learning (ML), today announced the signing of a Letter of Intent (LOI) with Global Care Innovations Inc. (GCI) and BitLab. The strategic partnership aims to deliver both quantum-secure data solutions and advanced AI-powered tools to healthcare providers across North America, enhancing patient care through cutting-edge technology. This partnership underscores Scope's positioning towards becoming a leader in secure technology applications for critical sectors like healthcare "This partnership with GCI and BitLab marks a significant step forward in our mission to secure sensitive health information against both current and future cyber threats," said James Young, CEO of Scope Technologies. "Our collaboration combines robust quantum security with innovative AI solutions, empowering healthcare providers to protect patient data while improving diagnostics and treatment options through advanced AI." Under the proposed terms of the LOI, GCI will license Scope's QSE suite of quantum-resistant encryption and decentralized storage solutions, providing HIPAA-compliant, secure data management for healthcare organizations. Additionally, BitLab, a Toronto-based technology innovation lab, will serve as the primary development partner, leveraging Scope's visual recognition and neural network technologies to create tailored AI applications that meet the unique needs of each healthcare provider. The collaboration's AI focus will enable healthcare providers to leverage Scope's visual recognition and annotation technology in multiple applications, developed by BitLab to improve diagnostics, streamline patient care, and enhance health outcomes. From AI-powered diagnostic tools to personalized treatment recommendations, Scope's technology offers a scalable foundation for various healthcare innovations, all underpinned by quantum-secure data storage to ensure patient data remains protected. "Scope's technology aligns perfectly with our vision of transforming healthcare through AI-driven solutions and secure data management," said Dr. Ragui Ibrahim, CEO of GCI. "This partnership enables us to expand our offerings to healthcare providers, ensuring that data is safeguarded both today and as we move into a quantum-powered future." On the quantum security side, GCI will integrate Scope's QSE platform to offer both quantum-resistant data backups and individual patient data vaults, designed to meet or exceed regulatory standards for data protection. "Our focus at BitLab is on delivering scalable, innovative solutions in AI and MedTech," said Shoukri Kattan, CEO of BitLab. "By integrating Scope's advanced AI and quantum security capabilities, we're setting new benchmarks for healthcare technology and improving the quality of care across the sector." The transaction is subject to the parties entering into a definitive agreement. CONTINUED... Read this and more news for Scope AI at: https://usanewsgroup.com/2024/04/26/the-currency-of-tomorrow-why-investing-in-cutting-edge-ai-recognition-tech-could-mean-big-money/ In other industry developments and happenings in the market this week include: SEALSQ Corp. LAES, a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, recently announced that its secure digital identity ecosystem empowers and fortifies next-generation 5G networks against cyber-Threats, safeguards user privacy, and upholds data sovereignty. This comes less than a month after SEALSQ announced that its Post Quantum products and services are designed to respond to the weakness of RSA algorithms to quantum computers recently exposed by Chinese Researchers. In response to the growing quantum threat, SEALSQ will not only offer to the market in 2025 a new generation of Quantum Resistant chips but also integrate (parent company) WISeKey's latest advancements in Post-Quantum Encryption in its PKI as-a-service platform (INeS). "These chips represent a transformative leap in cybersecurity," said Jean Pierre Enguent, CTO of SEALSQ. "As quantum computing capabilities advance, the vulnerabilities of current encryption methods become increasingly apparent. With our QS7001 and QVault TPM, we are set to provide industries and governments with the tools they need to safeguard their data and devices against the looming quantum threat." D-Wave Quantum Inc. QBTS, a leader in quantum computing systems, software, and services and the world's first commercial supplier of quantum computers, recently announced its participation in the University of Southern California's (USC) Quantum Technologies Forum. At the event, D-Wave presented the latest advancements in its annealing quantum computing technology and highlight real-world use cases from both commercial and research customers. "Our quantum system at USC plays an important role in supporting the university's efforts to serve as an epicenter of quantum research and education," said Lorenzo Martinelli, Chief Revenue Officer at D-Wave. "Our 5,000+ qubit quantum computer - currently the world's largest quantum computer - gives enterprise users, researchers and public sector organizations incredibly powerful computational capabilities for solving complex problems, and we look forward to continuing our collaboration with USC to advance scientific progress and business transformation." Rigetti Computing, Inc. RGTI RGTIW)), a pioneer in full-stack quantum-classical computing, recently announced its CEO Dr. Subodh Kulkarni's keynote presentation at SEMICON Europa 2024, discussing the potential transformative power of superconducting quantum computing and how Rigetti is delivering hands-on access to state-of-art quantum hardware to enable research and innovation to continue to advance the industry. "We believe that superconducting qubits are the leading modality for high performance quantum computers," said Dr. Kulkarni. "Superconducting qubits are manufactured using well established semiconductor and manufacturing techniques, and can execute faster gate operations than other modalities. Rigetti's system gate speeds consistently achieve an active duration of 60-80ns, which is several orders of magnitude faster than other modalities such as ion traps and neutral atoms. Our new multi-chip architecture will combine our strengths across our technology stack, and will be the result of our leadership in modular QPU design and performance optimization." IonQ, Inc. IONQ, a leader in the quantum computing and networking industry, recently announced the issuance of five new U.S. patents designed to deliver benefits across multiple industries and applications. With the pending acquisition of Qubitekk's 118 patents, IonQ will have a total of over 600 U.S. and international issued and pending patents, standing apart from similarly-sized quantum companies based on its strength of IP protection and extensive combination of patents across different verticals. "IonQ's robust and growing portfolio of patents is a direct result of the strategy set forth five years ago, which entails developing and owning quantum technologies across multiple industries and applications," said Peter Chapman, President and CEO of IonQ. "These patents put IonQ in a position to continue to develop scalable, high performance systems to solve some of the world's most complex questions, under the protection of the U.S. Patent and Trademark Office." IonQ has made strategic technological and architectural choices to uniquely balance the core elements of commercial advantage - performance, scale, and enterprise-grade capabilities - and these patents represent leadership in all of those key areas. The new patents announced to build upon IonQ's technical achievements including quantum circuit optimization, improved gate operations, reduced noise, error mitigation techniques, and multi-beam improvements. Article Source: https://usanewsgroup.com/2024/04/26/the-currency-of-tomorrow-why-investing-in-cutting-edge-ai-recognition-tech-could-mean-big-money/ CONTACT: USA NEWS GROUP [email protected] (604) 265-2873 DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA News Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. ("MIQ"). MIQ has been paid a fee for Scope Technologies Corp. advertising and digital media from the company directly. There may be 3rd parties who may have shares Scope Technologies Corp., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Scope Technologies Corp. which were purchased as a part of a private placement. MIQ reserves the right to buy and sell, and will buy and sell shares of Scope Technologies Corp. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through further private placements and/or investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. View original content:https://www.prnewswire.com/news-releases/with-quantum-threats-looming-major-healthcare-players-turn-to-quantum-secure-data-solutions-302305549.html SOURCE USA News Group Market News and Data brought to you by Benzinga APIs

Strategic Alliance with Global Care Innovations and BitLab to Drive Advanced AI and Quantum Security Solutions for Healthcare Across North America - Scope Technologies (OTC:SCPCF)

Collaboration to Drive Innovation in Healthcare with Secure AI Applications and Quantum-Resistant Data Solutions VANCOUVER, BC, Nov. 14, 2024 /PRNewswire/ -- Scope Technologies Corp. SCPE SCPCF VN ("Scope" or the "Company") is pleased to announce the signing of a Letter of Intent (the "LOI") with Global Care Innovations Inc. ("GCI") and BitLab. This strategic partnership aims to deliver both quantum-secure data solutions and advanced AI-powered tools to healthcare providers across North America, enhancing patient care through cutting-edge technology. This partnership underscores Scope's positioning towards becoming a leader in secure technology sectors like Healthcare. Under the proposed terms of the LOI, GCI will license Scope's QSE suite of quantum-resistant encryption and decentralized storage solutions, providing HIPAA-compliant, secure data management for healthcare organizations. Additionally, BitLab, a Toronto-based technology innovation lab, will serve as the primary development partner, leveraging Scope's visual recognition and neural network technologies to create tailored AI applications that meet the unique needs of each healthcare provider. "This partnership with GCI and BitLab marks a significant step forward in our mission to secure sensitive health information against both current and future cyber threats," said James Young, CEO of Scope Technologies Corp. "Our collaboration combines robust quantum security with innovative AI solutions, empowering healthcare providers to protect patient data while improving diagnostics and treatment options through advanced AI." The collaboration's AI focus will enable healthcare providers to leverage Scope's visual recognition and annotation technology in multiple applications, developed by BitLab to improve diagnostics, streamline patient care, and enhance health outcomes. From AI-powered diagnostic tools to personalized treatment recommendations, Scope's technology offers a scalable foundation for various healthcare innovations, all underpinned by quantum-secure data storage to ensure patient data remains protected. On the quantum security side, GCI will integrate Scope's QSE platform to offer both quantum-resistant data backups and individual patient data vaults, designed to meet or exceed regulatory standards for data protection. GCI CEO Dr. Ragui Ibrahim shared, "Scope's technology aligns perfectly with our vision of transforming healthcare through AI-driven solutions and secure data management. This partnership enables us to expand our offerings to healthcare providers, ensuring that data is safeguarded both today and as we move into a quantum-powered future." BitLab CEO Shoukri Kattan added, "We're excited to be part of this transformative partnership. Our focus at BitLab is on delivering scalable, innovative solutions in AI and MedTech. By integrating Scope's advanced AI and quantum security capabilities, we're setting new benchmarks for healthcare technology and improving the quality of care across the sector." The transaction is subject to the parties entering into a definitive agreement. About Global Care Innovations Inc. Global Care Innovations (GCI) is a healthcare technology leader focused on advancing patient care through AI-powered solutions. Headquartered in Montreal, Quebec, GCI serves healthcare providers across North America with telemedicine, remote monitoring, and advanced data analytics solutions. https://www.globalcareinnovations.com/ About BitLab BitLab is a Toronto-based technology innovation lab focused on transforming the healthcare sector with cutting-edge solutions in AI, MedTech, and Digital Health. BitLab partners with ambitious organizations to create custom, scalable applications that drive innovation, elevate patient care, and set new industry benchmarks in medical technology and wellness. https://www.bitlab.co/ Additionally, Scope announces that, further to its news releases dated September 13, 2024 and September 20, 2024, it has made additional payments to Creative Direct Marketing Group Inc. ("CDMG") for investor relations and marketing services to raise public awareness of the Company and increase brand awareness of the QSE platform. As set out in Scope's previous news release, CDMG will provide investor relations, market awareness and brand growth services through the creation and distribution of marketing materials (including print, digital and video). Scope made initial payments of US $997,100 to CDMG for their services. Scope has now paid CDMG an additional US $797,804 thereby increasing the total amount to US $1,794,904 for investor relations and marketing services that will end on December 20, 2024. CDMG is based in Nashville Tennessee and does not have any prior relationship with Scope and is an arm's length party. To the best of Scope's knowledge, CDMG does not hold, directly or indirectly, any securities of Scope or have any right to acquire any such securities. The compensation payable to CDMG does not include any securities of Scope. The contact information for CDMG is Creative Direct Marketing Group, Inc., 1313 4th Avenue North, Nashville, TN 37208, Phone: 615-814-6633; Email: [email protected] Scope has also engaged the market awareness and brand growth services through the creation and distribution of digital marketing materials of Plutus Invest & Consulting GmbH (28199 Bremen, Germany) ("Plutus") for a 12 month campaign commencing on November 15, 2024 and ending on December 15, 2025 for the total amount of EUR 107,500. Plutus is based in Bremen, Germany and does not have any prior relationship with Scope and is an arm's length party. To the best of Scope's knowledge, Plutus does not hold, directly or indirectly, any securities of Scope or have any right to acquire any such securities. The proposed compensation for Plutus does not include any securities of Scope. The contact information of Plutus is Plutus Invest & Consulting GmbH, 28199 Bremen, Germany. +49 (0) 172 422 69 58, [email protected] About Scope Technologies Corp. Scope Technologies Corp., headquartered in Vancouver, British Columbia, is a pioneering technology company specializing in quantum security and machine learning. Through its flagship brands -- QSE and GEM AI -- Scope provides advanced solutions in quantum encryption and neural networks, empowering businesses and individuals with secure, scalable technologies that drive growth and operational efficiency. LinkedIn: scope-technologies-corp Facebook: Scope Technologies Corp Twitter: @ScopeTechCorp Contact Information: James Young CEO, Scope Technologies Corp. Email: [email protected] Phone: +1 604-416-1720 Website: www.scopetechnologies.io Cautionary Note Regarding Forward-Looking Statements This news release contains forward-looking statements that constitute forward-looking information (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements in this news release that are not purely historical statements of fact are forward-looking statements and include statements regarding beliefs, plans, expectations, future, strategy, objectives, goals and targets, and more specifically, the use of proceeds of the Offering. Although the Company believes that such statements are reasonable and reflect expectations of future developments and other factors which management believes to be reasonable and relevant, the Company can give no assurance that such expectations will prove to be correct. Forward-looking statements are typically identified by words such as: "believes", "expects", "aim", "anticipates", "intends", "estimates", "plans", "may", "should", "would", "will", "potential", "scheduled" or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved. Forward-looking statements involve known and unknown risks and are based on assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, including, but not limited to, those risks and assumptions described in the Company's prospectus dated August 10, 2022, a copy of which is available under the Company's profile on SEDAR at www.sedar.com. While Scope considers these assumptions to be reasonable, based on information currently available, they may prove to be incorrect. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this press release. In addition, forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions, continued satisfaction of Canadian Securities Exchange requirements, product safety and recalls, regulatory compliance and risks associated with the Company's business. For more information on the risks, uncertainties and assumptions that could cause anticipated opportunities and actual results to differ materially, please refer to the risk factors set out in the Company's prospectus dated August 10, 2022, a copy of which is available under the Company's profile on SEDAR at www.sedar.com. Forward-looking statements are made as of the date of this news release and, unless required by applicable law, the Company assumes no obligation to update the forward looking statements or to update the reasons why actual results could differ from those projected in these forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary statement. The Canadian Securities Exchange has in no way passed upon the merits of the business of the Company and has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof. Logo - https://mma.prnewswire.com/media/2521783/5027139/Scope_Technologies_Corp_Logo.jpg View original content to download multimedia:https://www.prnewswire.com/news-releases/strategic-alliance-with-global-care-innovations-and-bitlab-to-drive-advanced-ai-and-quantum-security-solutions-for-healthcare-across-north-america-302305518.html SOURCE Scope Technologies Corp. Market News and Data brought to you by Benzinga APIs